Zasadzińska, M., & Borowski, G. (2025). Semaglutide as a promising treatment for metabolic dysfunction-associated steatotic liver disease. Journal of Medical Science, 94(1), 79. https://doi.org/10.20883/medical.e1219
Chicago Style (17th ed.) CitationZasadzińska, Maria, and Grzegorz Borowski. "Semaglutide as a Promising Treatment for Metabolic Dysfunction-associated Steatotic Liver Disease." Journal of Medical Science 94, no. 1 (2025): 79. https://doi.org/10.20883/medical.e1219.
MLA (9th ed.) CitationZasadzińska, Maria, and Grzegorz Borowski. "Semaglutide as a Promising Treatment for Metabolic Dysfunction-associated Steatotic Liver Disease." Journal of Medical Science, vol. 94, no. 1, 2025, p. 79, https://doi.org/10.20883/medical.e1219.
Warning: These citations may not always be 100% accurate.